Brain- and Heart-Type Fatty Acid-Binding Proteins in the Brain: Tissue Distribution and Clinical Utility
Author(s) -
Maurice M. A. L. Pelsers,
Thorsten Hanhoff,
D. van der Voort,
Baer Arts,
Maarten Peters,
Rudolf Ponds,
Adriaan Honig,
Wojtek Rudzinski,
Friedrich Spener,
Jelle R. de Kruijk,
A. Twijnstra,
Wim Th. Hermens,
Paul P.C.A. Menheere,
Jan F. C. Glatz
Publication year - 2004
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2003.030361
Subject(s) - enolase , heart type fatty acid binding protein , glial fibrillary acidic protein , pons , fatty acid binding protein , pathology , cerebellum , medicine , striatum , chemistry , endocrinology , biochemistry , immunohistochemistry , gene , dopamine
Detection of brain injury by serum markers is not a standard procedure in clinical practice, although several proteins, such as S100B, neuron-specific enolase (NSE), myelin basic protein, and glial fibrillary acidic protein, show promising results. We investigated the tissue distribution of brain- and heart-type fatty acid-binding proteins (B-FABP and H-FABP) in segments of the human brain and the potential of either protein to serve as plasma marker for diagnosis of brain injury.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom